Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Using Public Relations to Launch, Grow and Extend Your Brands

Published by: Best Practices, LLC

Published: Mar. 1, 2009 - 108 Pages


Table of Contents


EXECUTIVE SUMMARY

Introduction

Research Approach

Participating Companies

Table 1.1: Participating Companies

Figure 1.1: Participant Job Titles

Figure 1.2: Benchmark Partners’ Experience

Definitions and Abbreviations

Report Structure and Organization

Key Findings


USING PUBLIC RELATIONS TOOLS FOR OPTIMAL ADVANTAGE

Figure 2.1: Apply Public Relations Tools and Tactics throughout the Lifecycle

Figure 2.2: Public Relations Tool Effectiveness Changes Over the Brand Lifecycle

Figure 2.3: Media Interviews Get Company’s Message Out Best

Figure 2.4: Blogs and Social Networks Get Message Out in New Ways

Figure 2.5: Patient Groups, Human-Interest Key to Informing Patients and Family

Figure 2.6: Public Relations Positioning Tactics Offer Brand Teams Many Options

Figure 2.7: Human-Interest Stories Resonate with Patients, Media

Figure 2.8: Tactical Elements Appealing to Consumers Rated Best Public Relations Calls-to-Action

Figure 2.9: Ask Physician about Condition Rates Highest

Figure 2.10: Public Relations Calls-to-Action Direct Consumers to Experts & Expertise

Figure 2.11: Inform and Inspire Consumers to Take Action on Their Own Behalf

Figure 2.12: Web-based Calls-to-action Direct Patients to Resources

Figure 2.13: Medical Condition Websites are Most Highly Rated

Figure 2.14: Brand Websites Have More Options to Engage Consumers Resources and Support Services

Figure 2.15: Consumers Relate Well to Patient Stories

Figure 2.16: Best Web-Based Resources Inform and Engage Patients

Figure 2.17: Testimonials Offer Valuable Hope and Tips for Patients

Figure 2.18: Patient Advocacy Groups Are Key Partners

Figure 2.19: Key Public Relations Support Resources Help Inform Patients

Figure 2.20: Trusted Information Sources are Best Support Service Effectiveness, Timing and Budget

Figure 2.21: Pre-Launch, Launch & Growth Phases Benefit Greatly From Public Relations

Figure 2.22: Public Relations Budgets as Percent of Annual Marketing Spend

Figure 2.23: Measuring Public Relations is a Double-Edged Sword

Figure 2.24: Public Relations Performance Metrics Are Critical but Imprecise

Figure 2.25: Begin Public Relations early to bridge From One Brand To Successor


PRE-LAUNCH

Figure 3.1: Public Relations Can Create Buzz for New Treatment Paradigms

Figure 3.2: Formula for Bringing Non-Intuitive Mechanism of Action Medicines To Market

Figure 3.3: Public Relations Tool Effectiveness at Pre-Launch

Figure 3.4: Employ Public Relations to Reach Consumers through Patient Advocacy Groups

Figure 3.5: Early Public Relations Guides Consumers to Trusted Third-Party Info Resources

Figure 3.6: Introduce New Medical Ideas through Third-Party Expertise: Cymbalta

Figure 3.7: Inform Consumers through PR, Educational Messages & Personal Stories: Cymbalta

Figure 3.8: Shaping the Market for Successful Entry of New Products: Rituxan

Figure 3.9: Early Advisory Board Harvests Insights & Seeds New Ideas

Figure 3.10: Dare to Kick-Start Debate Before Full Clinical Data are Available

Figure 3.11: Incite Scientific Discussion - But Don’t Promote Off-Label

Figure 3.12: Pre-Launch Scientific Communications

Figure 3.13: B-Cell Dinners: Use Peer-to-Peer Discussions to Extend Science

Figure 3.14: Seminars and Congresses Extend Message to Broader Audience

Figure 3.15: Carefully Manage Expectations Pre-Launch

Figure 3.16: Carefully Manage Expectations Post-Launch

Figure 3.17: Blue Print for Market-Entry Success


LAUNCH

Figure 4.1: Using Experts, Media and Ed Events to Educate at Launch

Figure 4.2: Build Positive Coverage by Providing Media Access to KOLs

Figure 4.3: Media Spotlights Can Reach Millions in a Few Seconds

Figure 4.4: Human-Interest Positioning Touches Hearts

Figure 4.5: Patient Advocacy Groups Are Trusted Sources of Information

Figure 4.6: Differentiating a Product Means Building Advocacy Group Bridges

Figure 4.7: High-Impact Public Relations Campaigns Relate the Medical Condition To the Consumer

Figure 4.8: Relate the Medical Condition to the Consumer

Figure 4.9: Employ Public Relations Tools to Help Patients Assess Their Personal Risk

Case Study Spotlight: Slentrol

Figure 4.10: Pfizer Focuses Its Marketing Skills on Animal Health

Figure 4.11: Engage Consumers in Disease Awareness Research

Figure 4.12: Later Public Relations Drives Consumers to Branded Website

Figure 4.13: BARC as a Diagnostic Tool

Figure 3.14: New Media Public Relations Were Integral to Slentrol’s

Campaign


BRAND-BUILDING

Figure 5.1: Public Relations Tools, Post-Launch

Figure 5.2: Websites with Referral Mechanisms Expand Reach

Figure 5.3: Public Relations Success Stories Often Involve Partnerships

Figure 5.4: Employ Public Relations Lifestyle Campaigns to Educate and

Personalize the Condition

Figure 5.5: Edgy Public Relations Raises Awareness for Symptomless Conditions

Case Study Spotlight: Flomax

Figure 5.6: Anchor Brand Positioning Public Relations in Science, Safety, and Unmet Need

Figure 5.7: A Celebrity Spokesperson Can Help Personalize and Educate

Figure 5.8: Flomax Branded Website around the One-Week Challenge

Figure 5.9: Websites Are an Essential Tool in Patient and Family Education

Figure 5.10: Motivate Men to Seek “One Week” Improvement in Quality Of Life

Figure 5.11: Target Patient’s Family to Accelerate Treatment Pathway


LATE-LIFE MANAGEMENT

Figure 6.1: Later Stage Public Relations Tool Effectiveness

Figure 6.2: Position Product Public Relations to Reflect Total Cost Benefits

Figure 6.3: Public Relations Leveraging: Flomax

Case Study Spotlight: Nexium

Figure 6.4: Build Bridges between Product Generation to Transition Patients

Figure 6.5: Provide Info Support throughout the Customer Lifecycle

Figure 6.6: Employ Tools to Seed and Grow Relationships with Patients in Chronic Care Conditions

Figure 6.7: Education Tools Inform and Help Patients Self-Diagnose

Figure 6.8: Polls Educate, Inform & Engage Patients

Figure 6.9: Engage Patients on Lifestyle Fronts

Figure 6.10: Employ Technologies to Extend Education to Patient Populations

Figure 6.11: Public Relations Campaigns Trumpet “Nexium-Kids” Version

Figure 6.12: A Celebrity Spokesperson Helps to Humanize Medical Conditions


PATENT EXPIRATION MANAGEMENT

Figure 7.1: Effective Public Relations Tools, Patent Expiration

Case Study Spotlight: Fluvirin

Figure 7.2: Use YouTube to Create Buzz and Flu Awareness

Figure 7.3: Use a Contest to Engage Amateurs and Professionals


LESSONS LEARNED

General Good Practices

Figure 8.1: Public Relations Tools Help Educate and Inform the Market

Engage, Inform and Educate

Tailor Late-Stage Tactics to Reach Select Sub-Populations

Bridge the Gap between Product Generations

Abstract

Savvier consumers and competition from generic drugs have made commercial success, whether at market entry or during brand maturity, more elusive. At the same time, new technologies have greatly expanded the ability of cost-efficient Public Relations to support pharmaceutical brand growth.

Thus, while industry trends introduce challenges to product commercialization, technology is enabling PR leaders to fashion innovative PR campaigns. New media channels like the Internet have improved the reach of Public Relations through such forums as online disease state awareness groups and brand websites. The immediacy of these media has also enhanced the opportunity for shrewdly timing and executing PR activities in the product lifecycle.

This Best Practices, LLC benchmarking report identifies the most current and effective PR tools and calls-to-action, and explores how top companies align these tactics with each stage of a product’s lifecycle. Pharmaceutical executives and directors can use this research to optimize Public Relations during launch and brand-building years, and implement a PR strategy that can help build a bridge from first to next-generation product success.

This research also features four case studies detailing Public Relations success stories, all at different lifecycle stages: Slentrol (Product Launch), Flomax (Brand-Building), Nexium (Product Maturity) and Fluvirin (Patent Expiration).

INDUSTRIES PROFILED:

Health Care; Pharmaceutical; Biotechnology; Chemical

COMPANIES PROFILED:

Abbott; AstraZeneca; AtheroGenics; Boehringer Ingelheim; Boiron; Cubist Pharmaceuticals; Emcure; Farmasa Schwabe; Gebauer Company; Jazz Pharmaceuticals; Johnson & Johnson; Merck Serono; Novartis; Novo Nordisk; Pfizer; Solvay; Wyeth

STUDY SNAPSHOT

Marketing and Public Relations executives, directors and managers at 18 pharmaceutical companies participated in an in-depth online survey, and six executives, via deep-dive interviews, contributed their insights to this report. This research yields extensive benchmarking data on and best practices for achieving Public Relations excellence throughout the entire life of a product. Core topics covered include:
  • Using Public Relations Tools for Optimal Advantage
  • Public Relations during Pre-Launch
  • Public Relations during Launch
  • Public Relations during Brand-Building
  • The Role of Public Relations in Late-Life Management
  • Public Relations and Patent Expiration Management
  • Ideal Budget Ratios and Performance Measurements
  • Lesson Learned and General Good Practices
Four case studies are featured, detailing Public Relations success stories at different lifecycle stages: Slentrol (Product Launch), Flomax (Brand-Building), Nexium (Product Maturity) and Fluvirin (Patent Expiration).

KEY FINDINGS

Among the findings that emerged from this research were the following:

Public Relations in Launch & Brand-Building: The lifecycle phases where PR tactics appeared to be the most effective and actively used were at launch and the brand-building years. Websites are key tools for reaching patients, family members and physicians during these phases. Nearly two-thirds of all research participants positively assessed the following PR tools during launch and brand building years: use of the media, appeals to trusted experts, conducting educational events, producing educational materials and advertorials and sponsoring patient advocacy groups.

PR Relevance to Patients & Consumers: Field research revealed a “holy trinity” for PR specialists. The three aspects of this operational strategy are human-interest positioning, lifestyle positioning and family relevance positioning. Public Relations campaigns that touch these groups tend to engage consumers and win media attention.

Building Bridges: Integrated Public Relations and communication strategies helped AstraZeneca and Eli Lilly build sturdy bridges from Prilosec to Nexium and from Prozan to Cymbalta. This “bridge building” requires good planning and, ideally, should commence at the back end of the first-generation product’s lifecycle.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009